BRUKER CORPORATION Contract Liability (Deferred Revenue)
BRUKER CORPORATION (BRKR) had Contract Liability (Deferred Revenue) of $444.60 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-05
- 2026-06-30: Contract with Customer, Liability, Current $444.60M.
- 2026-03-31: Contract with Customer, Liability, Current $479.70M.
- 2025-12-31: Contract with Customer, Liability, Current $441.30M.
- 2025-09-30: Contract with Customer, Liability, Current $455.40M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $444.60M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $479.70M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $441.30M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $455.40M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $478.10M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $470.60M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $438.20M 10-K · filed 2026-02-27 |
| 2024-09-30 | $466.70M 10-Q · filed 2024-11-07 |
| 2023-12-31 | $400.00M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $218.00M 10-K · filed 2023-03-01 |
| 2022-09-30 | $175.50M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $196.70M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $214.70M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $197.50M 10-K · filed 2023-03-01 |
| 2021-09-30 | $178.30M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $192.90M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $182.20M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $189.20M 10-K · filed 2022-02-28 |
| 2019-12-31 | $137.90M 10-K · filed 2021-03-01 |
| 2019-09-30 | $126.10M 10-Q · filed 2019-11-04 |
| 2018-12-31 | $124.40M 10-Q · filed 2019-11-04 |
| 2018-09-30 | $110.40M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $109.60M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $125.30M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $111.70M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |